Kesava Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-01-2025
- Paid Up Capital ₹ 0.20 M
as on 17-01-2025
- Company Age 10 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
as on 17-01-2025
- Revenue -9.84%
(FY 2022)
- Profit -25.58%
(FY 2022)
- Ebitda -18.98%
(FY 2022)
- Net Worth 20.10%
(FY 2022)
- Total Assets 7.34%
(FY 2022)
About Kesava Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹15.00 Cr.
Silky Agarwal and Ashok Agarwal serve as directors at the Company.
- CIN/LLPIN
U85110AS2015PTC011997
- Company No.
011997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Dibrugarh, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kesava Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Silky Agarwal  | Director | 07-Jan-2015 | Current |
| Ashok Agarwal | Director | 07-Jan-2015 | Current |
Financial Performance of Kesava Drugs.
Kesava Drugs Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.84% decrease. The company also saw a substantial fall in profitability, with a 25.58% decrease in profit. The company's net worth Soared by an impressive increase of 20.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kesava Drugs?
Unlock access to Kesava Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹150.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 15.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Feb 2021 | Indian Bank | ₹15.00 Cr | Open |
How Many Employees Work at Kesava Drugs?
Unlock and access historical data on people associated with Kesava Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kesava Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kesava Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.